CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 10 No. 8
 

Study Advocates Breast Ultrasound Screening as an Adjunct to Mammography

August 1, 1996

With improved instrumentation and scanning techniques, breast ultrasound screening is earning a prominent role in the detection of breast cancer in women with dense breasts when no lump is felt and no abnormalities are detected on the mammogram.

Results of a study by Barbara Weinstein, md, of Pittsburgh, Pennsylvania, and colleagues, led to the recommendation that complete bilateral breast ultrasound be done in women with dense breasts whenever a cancer is suspected. This recommendation applies particularly to cases in which breast-conservation surgery (lumpectomy) is being contemplated. The finding of an additional cancer site may indicate that more extensive surgery is necessary. The serendipitous finding in this study of nine breast cancers in women who had no suspicious mammographic finding suggests that the role of ultrasound in the detection of breast cancer in women with dense breasts needs to be investigated further.

According to Dr. Weinstein, "While it may not prove to be cost effective to screen all women with mammographically dense breasts by sonography, our study suggests that it should be considered as an adjunct to mammography for women with dense breasts who have a strong family history or personal history of breast cancer."

The authors' findings support breast ultrasound's value. In 20 women, breast cancer was found by sonography only. That is, no lump was felt in the area where the cancer was discovered, and no abnormal changes were present on the mammogram in this location. The women ranged in age from 34 to 83 years, with a median age of 52. The occult cancers ranged in size from 5 to 24 mm, with a median size of 9 mm. Of interest was the fact that 10 of the 20 women were at high risk for breast cancer: They had a mother or sister with breast cancer, or a personal history of breast cancer.

Nine of the cancers were discovered when a suspicious abnormality at a different location in the same breast was being evaluated. In two other instances, a second breast cancer was found in the opposite breast. Seven cancers were detected as an incidental finding in the same breast while unrelated benign abnormalities were being scanned. Two of the malignancies were detected in breasts scanned because of the marked degree of breast density found on the mammogram.

Expanded Use of Ultrasound

Although many imaging specialists advocate "targeted" breast ultrasound examinations (scanning only the area of breast that is in question), the authors of the study routinely surveyed the entire breast when the mammogram was limited by marked breast density. If there were any suspicious findings, both breasts were carefully scrutinized. All suspicious abnormalities were then further evaluated by means of fine-needle aspiration biopsy, core biopsy, and/or surgical excision. To date, the major indications for breast ultrasound include evaluation of suspected mammographic abnormalities, evaluation of palpable breast masses, and evaluation of symptomatic women who are under age 30, pregnant, or lactating. It is hoped that this study will expand the use of ultrasound, especially in cases in which the mammogram is limited by marked breast density.

Dr. Weinstein reported the study's findings on March 18 at the American Institute of Ultrasound in Medicine's 40th Annual Convention in New York.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy